Reaction
Small Intestine Carcinoma reporting signals
As of the last recalculation, Small Intestine Carcinoma appears in 2,223 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is RANITIDINE HYDROCHLORIDE (PRR 49.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranitidine Hydrochloride | 254 | 49.3 | 49.5 |
| Ranitidine | 701 | 47.7 | 47.9 |
| Octreotide Acetate | 41 | 12.7 | 12.8 |
| Dabrafenib | 9 | 4.0 | 4.0 |
| Trametinib | 9 | 3.5 | 3.5 |
| Trifluridine And Tipiracil | 4 | 3.5 | 3.5 |